SlideShare une entreprise Scribd logo
1  sur  13
Bayesian Decision Making in
     Clinical Research

    Dr. Bhaswat S. Chakrabortya
 a
  R&D, Cadila Pharmaceuticals Ltd.,
    Ahemdabad, Gujarat 387 810
Abstract
•   Objective: To demonstrate various applications of Bayesian statistics in evaluating evidence from
    clinical and epidemiological research and understanding their implications in conclusions of clinical
    trials, medical practice, guidelines and policies.
•   Methods: Conventional (Frequentist) and Bayesian theories of probabilities are compared and
    contrasted. Inference of the results of a clinical trial comparing treatments A and B was considered.
    Conventional analysis concluded that treatment A is superior because there is a low probability that
    such a significant difference would have been observed when the treatments were in fact equal.
    Bayesian analysis on the other hand looked at the observed difference and induced the likelihood of
    treatment A being superior to B. A couple of additional case studies were also considered. In all
    cases, relative merits of the two approaches were analyzed for medical practice, guidelines and
    policies.
•   Results: The conventional analysis showed a p value for the difference between treatments A and B is
    0.001, which is highly significant at α = 0.05. This means that the chance of observing this difference
    when A and B are in fact equal is 1in 1000. The Bayesian conditioned probability of A being superior
    to B was 0.999. Although the same conclusion was reached here, the next two case studies (1.
    whether cancer can be induced by proximity to high-voltage transmission lines and 2. an increased
    risk of venous thrombosis with third generation oral contraceptives) showed very different results
    leading to different conclusions.
•   Conclusions: Conventional and Bayesian inferences can be similar or different but the key difference
    between conventional and Bayesian reasoning is that the Bayesian believes that truth is subjective and
    naturally conditioned by the evidence. Almost all areas of clinical research and medicine now have
    applications of Bayesian statistics, one of the earliest being diagnostic medicine. From the results of
    the case studies, we shall also see the application of Bayesian methods clinical trials and
    epidemiology.
Rev. Thomas Bayes (1702-1761)
               •   Rev. Thomas Bayes noted that
                   sometimes the probability of a
                   statistical hypothesis is given before
                   event or evidence is observed
                   (Prior); he showed how to compute
                   the probability of the hypothesis
                   after some observations are made
                   (Posterior).

               •   Before Rev. Bayes, no one knew
                   how to measure the probability of
                   statistical hypotheses in the light of
                   data. Only it was known as to how
                   to reject a statistical hypothesis in
                   the light of data.
Bayes' Theorem
Let X1, X2, ... , Xn be a set of mutually exclusive events that
form the sample space S. Let Y be any event from the same
sample space, such that P(Y) > 0. Then,
                                    P( Xk ∩ Y )
    P( Xk | Y ) =                                                   ….Eq. 1
                     P( X1 ∩ Y ) + P( X2 ∩ Y ) + P( X3 ∩ Y )

Since P( Xk ∩ Y ) = P( Xk )*P( Y | Xk ), Bayes’ theorem can
also be expressed as
P( Xk | Y ) =                      P( Xk )*P( Y | Xk )
                P( X1 )*P( Y | X1 ) + P( X2 )*P( Y | X2 ) P( Xn )*P( Y | Xn )

                                                                  ….Eq. 2
Case Study 1 – A Superiority Trial:
        Conventional Statistics
• H0 : μA – μB ≤ δ
• H1 : μA – μB > δ
• The hypotheses were tested at level of significance α
  =0.05
• Experimental data was analyzed to find p = 0.001
   – (i.e., the probability of observing this difference by chance
     is 1 in 1000)
• The Null Hypothesis was rejected (conclusion:
  alternate is true – A is superior to B)
Case Study 1 – A Superiority Trial:
             Bayes’ Statistics
•   Let prior probability Treatment A being superior to Treatment B, P( X A ) =
    0.8
•   and, therefore, prior probability Treatment A NOT being superior to
    Treatment B, P( XB ) = 0.2
•   Let experimental (RCTs) probability of concluding A is superior to B,
    when A is indeed superior, P(Y | XA) = 0.95
•   and, therefore, experimental probability of concluding A NOT being
    superior to B, when A is indeed superior, P(Y | X B) = 0.05
•   What we would like to know is the posterior or conditional probability of
    A indeed being superior to B when the experimental evidence is
    superiority of A (following Eq. 2):
      P( XA | Y ) =                  P( XA )*P( Y | XA )
                           P( XA )*P( Y | XA ) + P( XB )*P( Y | XB )
A Superiority Trial:
                Bayes’ Statistics contd.
                               P( XA )*P( Y | XA )
     P( XA | Y ) =
                      P( XA )*P( Y | XA ) + P( XB )*P( Y | XB )

                =              0.8*0.95
                          0.8*0.95 + 0.2*0.05


                =              0.76
                            0.76 + 0.01

                =              0.99
That is a 99% probability of the hypothesis that A is Superior to
  B!
Case Study 2
•   Case and the Problem
     – An elementary school staff was concerned that their high cancer rate could be
        due to two nearby high voltage transmission lines [1]

•   Data
     – there were 8 cases of invasive cancer over a long time among 145 staff
        members whose average age was between 40 and 44
     – based on the national cancer rate among woman this age
        (approximately 3/100), the expected number of cancers is 4.2

•   Assumptions
     – the 145 staff members developed cancer independently of each other
     – the chance of cancer, θ, was the same for each staff person

•   Therefore, the number of cancers, X, follows a binomial distribution:
     – X ~ bin (145, θ)
     – θ could be 0.03 (national cancer rate) or more, i.e., 0.04, 0.05, 0.06
Case Study 2 contd.
•   For each hypothesized θ, we use elementary results about the binomial
    distribution to calculate:

                           145
          P(X=8 | θ) =            θ8 (1 – θ)137
                            8
•   Theory A: P(X=8 | θ=0.03 ) ≈ 0.036; Theory B: P(X=8 | θ=0.04 ) ≈ 0.096
•   Theory C: P(X=8 | θ=0.05 ) ≈ 0.134; Theory D: P(X=8 | θ=0.06 ) ≈ 0.136
•   This is a ratio of approximately 1:3:4:4. So, Theory B explains the data
    about 3 times as well as theory A
•   Likelihood Principle:
     – Initially, P( X | θ ) is a function of two variables: X and θ.
     – But once X = 8 has been observed, then P( X | θ ) describes how well each
         theory, or value of θ explains the data. No other value of X is relevant.
     –   This is an example of the likelihood principal[2]
Case Study 2 contd..
•   Conventional Analysis:
•   Null hypothesis, H0: θ=0.03; Alternate hypothesis, H1: θ=0.03
•   p-value = P(X=8| θ=0.03)+ P(X=9| θ=0.03)+ +…+ P(X=145| θ=0.03)
              ≈ 0.07
•   At α=0.10, the null hypothesis will be rejected and conclusion would be
    that the high voltage has a significant effect on the cancer rate at the school


•   Bayesian Analysis:
•   P(A | X=8 ) = 0.23; P( B | X=8 ) = 0.21
•   P( C | X=8 ) = 0.28; P( D | X=8 ) = 0.28
•   The Bayesian P(θ > .03) ≈ 0.77, which would not be sufficient
    to reject the null hypothesis!!
Case Study 3
•   Case and the Problem
     – Four case-control studies (one nested in a cohort study) of third generation
         contraceptive pills containing desogestral and gestodene were compared with
         pills containing other progestagens for the relative risk of venous
         thromboembolism[3].
•   Bayesian Analysis:
     –   Showed the posterior distributions are much narrower than the prior distributions,
         indicating less doubt about the value of the true relative risk (odds ratio of 2.0).
         The data influenced the posterior distributions more than the prior distributions, such
         that they are centred on log(1.69) and log(1.76) respectively, and the probability of
         the true relative risk being greater than 1 is more than 0.999 in both cases.
•   Why was not this risk picked up by conventional analysis?
     –   As we illustrated in previous examples, conventional analysis does not calculate the
         probability of a hypothesis being true given the data
•   The real scientific question could have been:
     – "What is the probability that the third generation pills increase the risk when
         compared to the others; what is the probability that they at least double the
         risk--as measured in the case-control study; and what is the 'median estimate'
         (as likely to be too small as too large)?" [4]
Conclusions
•   Conventional Statistics (Frequentists) make no claims about probabilities
     – E.g., the 95% CI of mean does not claim there is a 95% probability the mean is in that
       range
     – It only states that if the experiment was repeated 100 times, 95 times the estimated mean
       would lie that range
•   Likelihood also does not give you probability of a hypothesis – only the likelihood
    of the data given the hypothesis
•   Bayesian Statistics does give you the probability of a hypothesis being true given
    the data
     – This is closest to intuition and normal process of decision making
•   Three case studies
     – The first one shows, if the prior and posterior are equally influenced by data, then the
       conventional and Bayesian conclusions are nominally the same
     – However, in the second case, the conditioned (posterior) probability, although influenced
       by the data, did not yet call for a rejection of the hypothesis
     – And in the third case, the data changed the posterior probability so much that only the
       conditioned hypothesis was considered to be true
References

1. Brodeur P, “The Cancer at Slater School”, Annals of radiation,
   The New Yorker, December 7, 1992, p. 86.
2. http://www.home.uchicago.edu/~grynav/bayes/ABSLec1.ppt,
   access date 06.03.2009.
3. McPherson K. Third Generation Oral Contraception and
   Venous Thromboembolism. BMJ, 1995, 312, 68-9.
4. Lilford RJ, Braunholtz D. The Statistical Basis of Public
   Policy: a Paradigm Shift is Overdue. BMJ, 1996, 313, pp. 603-
   7.

Contenu connexe

Tendances

Tendances (20)

Bayesian inference
Bayesian inferenceBayesian inference
Bayesian inference
 
Bayesian statistics using r intro
Bayesian statistics using r   introBayesian statistics using r   intro
Bayesian statistics using r intro
 
Introduction to Bayesian Methods
Introduction to Bayesian MethodsIntroduction to Bayesian Methods
Introduction to Bayesian Methods
 
Logistic regression
Logistic regressionLogistic regression
Logistic regression
 
Testing Hypothesis
Testing HypothesisTesting Hypothesis
Testing Hypothesis
 
Introduction to statistical software R
Introduction to statistical software RIntroduction to statistical software R
Introduction to statistical software R
 
Introduction to Bayesian Inference
Introduction to Bayesian InferenceIntroduction to Bayesian Inference
Introduction to Bayesian Inference
 
Interim analysis in clinical trials (1)
Interim analysis in clinical trials (1)Interim analysis in clinical trials (1)
Interim analysis in clinical trials (1)
 
R programming language
R programming languageR programming language
R programming language
 
Markov Chain Monte Carlo Methods
Markov Chain Monte Carlo MethodsMarkov Chain Monte Carlo Methods
Markov Chain Monte Carlo Methods
 
Support Vector machine
Support Vector machineSupport Vector machine
Support Vector machine
 
Ridge regression, lasso and elastic net
Ridge regression, lasso and elastic netRidge regression, lasso and elastic net
Ridge regression, lasso and elastic net
 
Introduction to R
Introduction to RIntroduction to R
Introduction to R
 
Introduction to Data Analysis With R and R Studio
Introduction to Data Analysis With R and R StudioIntroduction to Data Analysis With R and R Studio
Introduction to Data Analysis With R and R Studio
 
Multiple Regression and Logistic Regression
Multiple Regression and Logistic RegressionMultiple Regression and Logistic Regression
Multiple Regression and Logistic Regression
 
An overview of Bayesian testing
An overview of Bayesian testingAn overview of Bayesian testing
An overview of Bayesian testing
 
Data Science - Part XII - Ridge Regression, LASSO, and Elastic Nets
Data Science - Part XII - Ridge Regression, LASSO, and Elastic NetsData Science - Part XII - Ridge Regression, LASSO, and Elastic Nets
Data Science - Part XII - Ridge Regression, LASSO, and Elastic Nets
 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
 
Introduction to Rstudio
Introduction to RstudioIntroduction to Rstudio
Introduction to Rstudio
 
Introduction to Maximum Likelihood Estimator
Introduction to Maximum Likelihood EstimatorIntroduction to Maximum Likelihood Estimator
Introduction to Maximum Likelihood Estimator
 

Similaire à Bayesian decision making in clinical research

Similaire à Bayesian decision making in clinical research (20)

blood_red_demo.pptx
blood_red_demo.pptxblood_red_demo.pptx
blood_red_demo.pptx
 
Basic of Hypothesis Testing TEKU QM
Basic of Hypothesis Testing TEKU QMBasic of Hypothesis Testing TEKU QM
Basic of Hypothesis Testing TEKU QM
 
Test of significance
Test of significanceTest of significance
Test of significance
 
On the vexing dilemma of hypothesis testing and the predicted demise of the B...
On the vexing dilemma of hypothesis testing and the predicted demise of the B...On the vexing dilemma of hypothesis testing and the predicted demise of the B...
On the vexing dilemma of hypothesis testing and the predicted demise of the B...
 
Lec13_Bayes.pptx
Lec13_Bayes.pptxLec13_Bayes.pptx
Lec13_Bayes.pptx
 
Bayesian ijupls
Bayesian ijuplsBayesian ijupls
Bayesian ijupls
 
2.statistical DEcision makig.pptx
2.statistical DEcision makig.pptx2.statistical DEcision makig.pptx
2.statistical DEcision makig.pptx
 
Philosophy of Science and Philosophy of Statistics
Philosophy of Science and Philosophy of StatisticsPhilosophy of Science and Philosophy of Statistics
Philosophy of Science and Philosophy of Statistics
 
Bayesian data analysis1
Bayesian data analysis1Bayesian data analysis1
Bayesian data analysis1
 
Phil 6334 Mayo slides Day 1
Phil 6334 Mayo slides Day 1Phil 6334 Mayo slides Day 1
Phil 6334 Mayo slides Day 1
 
Test of-significance : Z test , Chi square test
Test of-significance : Z test , Chi square testTest of-significance : Z test , Chi square test
Test of-significance : Z test , Chi square test
 
The Statistics Wars: Errors and Casualties
The Statistics Wars: Errors and CasualtiesThe Statistics Wars: Errors and Casualties
The Statistics Wars: Errors and Casualties
 
hypotesting lecturenotes by Amity university
hypotesting lecturenotes by Amity universityhypotesting lecturenotes by Amity university
hypotesting lecturenotes by Amity university
 
Gerstman_PP09.ppt
Gerstman_PP09.pptGerstman_PP09.ppt
Gerstman_PP09.ppt
 
Gerstman_PP09.ppt
Gerstman_PP09.pptGerstman_PP09.ppt
Gerstman_PP09.ppt
 
Ppt1
Ppt1Ppt1
Ppt1
 
Hypothesis Testing
Hypothesis TestingHypothesis Testing
Hypothesis Testing
 
unit 3 -ML.pptx
unit 3 -ML.pptxunit 3 -ML.pptx
unit 3 -ML.pptx
 
Bayes' theorem
Bayes' theoremBayes' theorem
Bayes' theorem
 
ISBA 2016: Foundations
ISBA 2016: FoundationsISBA 2016: Foundations
ISBA 2016: Foundations
 

Plus de Bhaswat Chakraborty

Plus de Bhaswat Chakraborty (20)

Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
 
Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019
 
Respiratory studies right approach in designs dia 11 april 2019 r
Respiratory studies right approach  in designs dia 11 april 2019 rRespiratory studies right approach  in designs dia 11 april 2019 r
Respiratory studies right approach in designs dia 11 april 2019 r
 
Simplifying study designs and statistical models for new dose & dosage forms ...
Simplifying study designs and statistical models for new dose & dosage forms ...Simplifying study designs and statistical models for new dose & dosage forms ...
Simplifying study designs and statistical models for new dose & dosage forms ...
 
Equivalence approches for complex generics DIA 11 april 2019
Equivalence approches for complex generics DIA 11 april 2019 Equivalence approches for complex generics DIA 11 april 2019
Equivalence approches for complex generics DIA 11 april 2019
 
Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018
 
Writing scientific papers FINALDec 2018
Writing scientific papers FINALDec 2018Writing scientific papers FINALDec 2018
Writing scientific papers FINALDec 2018
 
Multidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
Multidisc review of NDAs and BLAs nipicon 2018 Dr. ChakrabortyMultidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
Multidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
 
Teaching by stories, anecdotes and historical facts sept 25 2018
Teaching by stories, anecdotes and historical facts sept 25 2018Teaching by stories, anecdotes and historical facts sept 25 2018
Teaching by stories, anecdotes and historical facts sept 25 2018
 
Orientation and Adaptation for Post-Graduate Pharmacy Programs
Orientation and Adaptation for Post-Graduate Pharmacy ProgramsOrientation and Adaptation for Post-Graduate Pharmacy Programs
Orientation and Adaptation for Post-Graduate Pharmacy Programs
 
Plagiarism and Techniques to Avoid Plagiarism
Plagiarism and Techniques to Avoid PlagiarismPlagiarism and Techniques to Avoid Plagiarism
Plagiarism and Techniques to Avoid Plagiarism
 
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
 
Ethics in Pharmacy
Ethics in Pharmacy Ethics in Pharmacy
Ethics in Pharmacy
 
Pharmacists in Drug Discovery & Development
Pharmacists in Drug Discovery & Development Pharmacists in Drug Discovery & Development
Pharmacists in Drug Discovery & Development
 
Clinical Development of Biosimilars
Clinical Development of Biosimilars Clinical Development of Biosimilars
Clinical Development of Biosimilars
 
Challenges in Phase III Cancer Clinical Trials
Challenges in Phase III Cancer Clinical Trials Challenges in Phase III Cancer Clinical Trials
Challenges in Phase III Cancer Clinical Trials
 
Bioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug Products
 
Bioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug Products
 
Protein binding of drugs and screening of drugs by physicochemical properties
Protein binding of drugs  and screening of drugs by physicochemical propertiesProtein binding of drugs  and screening of drugs by physicochemical properties
Protein binding of drugs and screening of drugs by physicochemical properties
 
Developing Protocols & Procedures for CT Data Integrity
Developing Protocols & Procedures for CT Data Integrity Developing Protocols & Procedures for CT Data Integrity
Developing Protocols & Procedures for CT Data Integrity
 

Dernier

🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
Call Girls In Delhi Whatsup 9873940964 Enjoy Unlimited Pleasure
 
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
chetankumar9855
 

Dernier (20)

Russian Call Girls Service Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...
Russian Call Girls Service  Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...Russian Call Girls Service  Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...
Russian Call Girls Service Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...
 
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
 
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
 
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
 
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
 
Call Girls Jaipur Just Call 9521753030 Top Class Call Girl Service Available
Call Girls Jaipur Just Call 9521753030 Top Class Call Girl Service AvailableCall Girls Jaipur Just Call 9521753030 Top Class Call Girl Service Available
Call Girls Jaipur Just Call 9521753030 Top Class Call Girl Service Available
 
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
 
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
 
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
 
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
 
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
 
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
 
Most Beautiful Call Girl in Bangalore Contact on Whatsapp
Most Beautiful Call Girl in Bangalore Contact on WhatsappMost Beautiful Call Girl in Bangalore Contact on Whatsapp
Most Beautiful Call Girl in Bangalore Contact on Whatsapp
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
 
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
 
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
 
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
 
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
 

Bayesian decision making in clinical research

  • 1. Bayesian Decision Making in Clinical Research Dr. Bhaswat S. Chakrabortya a R&D, Cadila Pharmaceuticals Ltd., Ahemdabad, Gujarat 387 810
  • 2. Abstract • Objective: To demonstrate various applications of Bayesian statistics in evaluating evidence from clinical and epidemiological research and understanding their implications in conclusions of clinical trials, medical practice, guidelines and policies. • Methods: Conventional (Frequentist) and Bayesian theories of probabilities are compared and contrasted. Inference of the results of a clinical trial comparing treatments A and B was considered. Conventional analysis concluded that treatment A is superior because there is a low probability that such a significant difference would have been observed when the treatments were in fact equal. Bayesian analysis on the other hand looked at the observed difference and induced the likelihood of treatment A being superior to B. A couple of additional case studies were also considered. In all cases, relative merits of the two approaches were analyzed for medical practice, guidelines and policies. • Results: The conventional analysis showed a p value for the difference between treatments A and B is 0.001, which is highly significant at α = 0.05. This means that the chance of observing this difference when A and B are in fact equal is 1in 1000. The Bayesian conditioned probability of A being superior to B was 0.999. Although the same conclusion was reached here, the next two case studies (1. whether cancer can be induced by proximity to high-voltage transmission lines and 2. an increased risk of venous thrombosis with third generation oral contraceptives) showed very different results leading to different conclusions. • Conclusions: Conventional and Bayesian inferences can be similar or different but the key difference between conventional and Bayesian reasoning is that the Bayesian believes that truth is subjective and naturally conditioned by the evidence. Almost all areas of clinical research and medicine now have applications of Bayesian statistics, one of the earliest being diagnostic medicine. From the results of the case studies, we shall also see the application of Bayesian methods clinical trials and epidemiology.
  • 3. Rev. Thomas Bayes (1702-1761) • Rev. Thomas Bayes noted that sometimes the probability of a statistical hypothesis is given before event or evidence is observed (Prior); he showed how to compute the probability of the hypothesis after some observations are made (Posterior). • Before Rev. Bayes, no one knew how to measure the probability of statistical hypotheses in the light of data. Only it was known as to how to reject a statistical hypothesis in the light of data.
  • 4. Bayes' Theorem Let X1, X2, ... , Xn be a set of mutually exclusive events that form the sample space S. Let Y be any event from the same sample space, such that P(Y) > 0. Then, P( Xk ∩ Y ) P( Xk | Y ) = ….Eq. 1 P( X1 ∩ Y ) + P( X2 ∩ Y ) + P( X3 ∩ Y ) Since P( Xk ∩ Y ) = P( Xk )*P( Y | Xk ), Bayes’ theorem can also be expressed as P( Xk | Y ) = P( Xk )*P( Y | Xk ) P( X1 )*P( Y | X1 ) + P( X2 )*P( Y | X2 ) P( Xn )*P( Y | Xn ) ….Eq. 2
  • 5. Case Study 1 – A Superiority Trial: Conventional Statistics • H0 : μA – μB ≤ δ • H1 : μA – μB > δ • The hypotheses were tested at level of significance α =0.05 • Experimental data was analyzed to find p = 0.001 – (i.e., the probability of observing this difference by chance is 1 in 1000) • The Null Hypothesis was rejected (conclusion: alternate is true – A is superior to B)
  • 6. Case Study 1 – A Superiority Trial: Bayes’ Statistics • Let prior probability Treatment A being superior to Treatment B, P( X A ) = 0.8 • and, therefore, prior probability Treatment A NOT being superior to Treatment B, P( XB ) = 0.2 • Let experimental (RCTs) probability of concluding A is superior to B, when A is indeed superior, P(Y | XA) = 0.95 • and, therefore, experimental probability of concluding A NOT being superior to B, when A is indeed superior, P(Y | X B) = 0.05 • What we would like to know is the posterior or conditional probability of A indeed being superior to B when the experimental evidence is superiority of A (following Eq. 2): P( XA | Y ) = P( XA )*P( Y | XA ) P( XA )*P( Y | XA ) + P( XB )*P( Y | XB )
  • 7. A Superiority Trial: Bayes’ Statistics contd. P( XA )*P( Y | XA ) P( XA | Y ) = P( XA )*P( Y | XA ) + P( XB )*P( Y | XB ) = 0.8*0.95 0.8*0.95 + 0.2*0.05 = 0.76 0.76 + 0.01 = 0.99 That is a 99% probability of the hypothesis that A is Superior to B!
  • 8. Case Study 2 • Case and the Problem – An elementary school staff was concerned that their high cancer rate could be due to two nearby high voltage transmission lines [1] • Data – there were 8 cases of invasive cancer over a long time among 145 staff members whose average age was between 40 and 44 – based on the national cancer rate among woman this age (approximately 3/100), the expected number of cancers is 4.2 • Assumptions – the 145 staff members developed cancer independently of each other – the chance of cancer, θ, was the same for each staff person • Therefore, the number of cancers, X, follows a binomial distribution: – X ~ bin (145, θ) – θ could be 0.03 (national cancer rate) or more, i.e., 0.04, 0.05, 0.06
  • 9. Case Study 2 contd. • For each hypothesized θ, we use elementary results about the binomial distribution to calculate: 145 P(X=8 | θ) = θ8 (1 – θ)137 8 • Theory A: P(X=8 | θ=0.03 ) ≈ 0.036; Theory B: P(X=8 | θ=0.04 ) ≈ 0.096 • Theory C: P(X=8 | θ=0.05 ) ≈ 0.134; Theory D: P(X=8 | θ=0.06 ) ≈ 0.136 • This is a ratio of approximately 1:3:4:4. So, Theory B explains the data about 3 times as well as theory A • Likelihood Principle: – Initially, P( X | θ ) is a function of two variables: X and θ. – But once X = 8 has been observed, then P( X | θ ) describes how well each theory, or value of θ explains the data. No other value of X is relevant. – This is an example of the likelihood principal[2]
  • 10. Case Study 2 contd.. • Conventional Analysis: • Null hypothesis, H0: θ=0.03; Alternate hypothesis, H1: θ=0.03 • p-value = P(X=8| θ=0.03)+ P(X=9| θ=0.03)+ +…+ P(X=145| θ=0.03) ≈ 0.07 • At α=0.10, the null hypothesis will be rejected and conclusion would be that the high voltage has a significant effect on the cancer rate at the school • Bayesian Analysis: • P(A | X=8 ) = 0.23; P( B | X=8 ) = 0.21 • P( C | X=8 ) = 0.28; P( D | X=8 ) = 0.28 • The Bayesian P(θ > .03) ≈ 0.77, which would not be sufficient to reject the null hypothesis!!
  • 11. Case Study 3 • Case and the Problem – Four case-control studies (one nested in a cohort study) of third generation contraceptive pills containing desogestral and gestodene were compared with pills containing other progestagens for the relative risk of venous thromboembolism[3]. • Bayesian Analysis: – Showed the posterior distributions are much narrower than the prior distributions, indicating less doubt about the value of the true relative risk (odds ratio of 2.0). The data influenced the posterior distributions more than the prior distributions, such that they are centred on log(1.69) and log(1.76) respectively, and the probability of the true relative risk being greater than 1 is more than 0.999 in both cases. • Why was not this risk picked up by conventional analysis? – As we illustrated in previous examples, conventional analysis does not calculate the probability of a hypothesis being true given the data • The real scientific question could have been: – "What is the probability that the third generation pills increase the risk when compared to the others; what is the probability that they at least double the risk--as measured in the case-control study; and what is the 'median estimate' (as likely to be too small as too large)?" [4]
  • 12. Conclusions • Conventional Statistics (Frequentists) make no claims about probabilities – E.g., the 95% CI of mean does not claim there is a 95% probability the mean is in that range – It only states that if the experiment was repeated 100 times, 95 times the estimated mean would lie that range • Likelihood also does not give you probability of a hypothesis – only the likelihood of the data given the hypothesis • Bayesian Statistics does give you the probability of a hypothesis being true given the data – This is closest to intuition and normal process of decision making • Three case studies – The first one shows, if the prior and posterior are equally influenced by data, then the conventional and Bayesian conclusions are nominally the same – However, in the second case, the conditioned (posterior) probability, although influenced by the data, did not yet call for a rejection of the hypothesis – And in the third case, the data changed the posterior probability so much that only the conditioned hypothesis was considered to be true
  • 13. References 1. Brodeur P, “The Cancer at Slater School”, Annals of radiation, The New Yorker, December 7, 1992, p. 86. 2. http://www.home.uchicago.edu/~grynav/bayes/ABSLec1.ppt, access date 06.03.2009. 3. McPherson K. Third Generation Oral Contraception and Venous Thromboembolism. BMJ, 1995, 312, 68-9. 4. Lilford RJ, Braunholtz D. The Statistical Basis of Public Policy: a Paradigm Shift is Overdue. BMJ, 1996, 313, pp. 603- 7.